Three dimensional ultrasonic molecular imaging of angiogenesis

Ultrasonic (US) molecular imaging (MI) relies on microbubble contrast agents (MCAs) adhering to ligand-specific biomarkers for characterizing diseased tissue in applications such as tumor angiogenesis. One drawback to traditional 2D US MI methods is the inability to completely characterize the three-dimensional (3D) in vivo environment. We attempt to improve targeted MCA visualization and quantification by performing US MI of tumors expressing αvβ3 in 3D space. 3D acquisitions were obtained on multiple rat fibrosarcoma tumors with a Siemens Sequoia system in CPS mode by mechanically scanning the transducer in the elevational direction across the tumor. Our US MI results show high targeting variability suggesting that individual 2D acquisitions can misrepresent more complex heterogeneous tissues. Our hypothesis is that 3D US MI will provide a more robust evaluation of disease progression than traditional methods.

[1]  Paul A Dayton,et al.  Quantitative Volumetric Perfusion Mapping of the Microvasculature Using Contrast Ultrasound , 2010, Investigative radiology.

[2]  Paul A Dayton,et al.  Advances in Molecular Imaging with Ultrasound , 2010, Molecular imaging.

[3]  Paul A Dayton,et al.  Improving Sensitivity in Ultrasound Molecular Imaging by Tailoring Contrast Agent Size Distribution: In Vivo Studies , 2010, Molecular imaging.

[4]  Katherine W. Ferrara,et al.  Lipid-Shelled Vehicles: Engineering for Ultrasound Molecular Imaging and Drug Delivery , 2009 .

[5]  J. Lindner,et al.  Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles. , 2009, Cardiovascular research.

[6]  Jonathan R. Lindner,et al.  Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography , 2009, Nature Reviews Cardiology.

[7]  F. Bengel.  Clinical Cardiovascular Molecular Imaging , 2009, Journal of Nuclear Medicine.

[8]  J. Hickson.  In vivo optical imaging: preclinical applications and considerations. , 2009, Urologic oncology.

[9]  K. Tachibana,et al.  A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Jameel A Feshitan,et al.  Microbubble size isolation by differential centrifugation. , 2009, Journal of colloid and interface science.

[11]  Sanjiv S Gambhir,et al.  Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. , 2008, Radiology.

[12]  Paul A Dayton,et al.  Molecular ultrasound imaging using microbubble contrast agents. , 2007, Frontiers in bioscience : a journal and virtual library.

[13]  William R Wagner,et al.  Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. , 2005, Cancer research.

[14]  S. Simon,et al.  Ultrasonic Analysis of Peptide- and Antibody-Targeted Microbubble Contrast Agents for Molecular Imaging of αvβ3-Expressing Cells , 2004 .

[15]  Jonathan R. Lindner,et al.  Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to &agr;v-Integrins , 2003, Circulation.

[16]  E. Unger,et al.  Targeted-Microbubble Binding Selectively to GPIIb IIIa Receptors of Platelet Thrombi , 2002, Investigative radiology.

[17]  Paul A Dayton,et al.  Targeted imaging using ultrasound , 2002, Journal of magnetic resonance imaging : JMRI.

[18]  S. Kaul,et al.  Noninvasive Ultrasound Imaging of Inflammation Using Microbubbles Targeted to Activated Leukocytes , 2000, Circulation.

[19]  J. G. Miller,et al.  A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.

[20]  Paul A. Dayton,et al.  Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. , 2008, Contrast media & molecular imaging.